Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

In the 1999 sci-fi classic The Matrix, “plugging in” symbolized digital enslavement. In 2025, for a paraplegia patient in ...

The Beijing-based AI-for-Science firm said the Series C round would fund hiring and R&D, as interest grows in using AI to ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Andhra Pradesh has announced an ambitious goal: to produce quantum computers within the next two years, with at least 85% of ...

After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma ...

The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

From AI simulations to energy-efficient manufacturing, learn how leaders in academia and industry are conducting responsible, ...